Believes the Substantial Premium Presented by Future Pak Merits Engagement
Believes a Sales Process Could Yield Well Over 100% Upside to the Stock
LOS ANGELES, April 19, 2024 (GLOBE NEWSWIRE) -- A fund managed by Butler Hall Capital LLC, with current ownership 350,000 shares of Vanda Pharmaceuticals Inc. (“Vanda” or the “Company”), has issued an open letter to the Company’s board of directors (the “Board”) regarding the potential bid for Vanda submitted by Future Pak, LLC (“Future Pak”).
A full copy of the letter is attached below and is available at:
http://ml.globenewswire.com/Resource/Download/9ee5bd01-bdbc-43f7-af2d-e4c34004b336
